Is RGC diluting shareholders?

Read three numbers together: shares outstanding over time (495.9M as of 2026-06-30), warrants that can convert into new shares (308,750 reported), and how much cash runway remains (~25.599793126659243 months). A company short on cash with live registrations is structurally likely to issue shares.

Where do these numbers come from?

SEC EDGAR only: the XBRL company-facts API for shares, warrants and cash, and filing metadata for registrations and pricings. Every figure shows its source form, and nothing here is estimated by us beyond the arithmetic stated next to it.

Why might a warrant tranche be missing from the table?

The tranche table is built from the dimensions the company tagged in its own 10-Q or 10-K XBRL. A tranche the filer chose not to dimension does not appear, and its absence proves nothing: the exhibits remain the ground truth. Everything shown carries the filing it came from.

Dilution profile // every instrument, one screen, from SEC filings

Regencell Bioscience Holdings Ltd (RGC)

CIK 1829667 · all EDGAR filings →

Overall dilution risk

HIGHworst of 4 computed sub-ratings (offering ability)

= the worst band among the computed sub-ratings, no hidden weighting

Offering ability

HIGHF-3ASR on file 2026-03-30

= is there a registration (S-1/S-3 family) on file without a later withdrawal

no structured fee data on the live registrations, so this is a yes/no, not a size

Overhead supply

LOWwarrants = 0% of O/S

= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)

warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this

Historical dilution

HIGH+3711% O/S in 3y

= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative

Cash need

LOW~25.6 months of runway

= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

Latest: 495.9M shares as of Jun 30, 2026 (20-F).

⊙

EVIDENCE — filed/published fact

SourceSEC XBRL, cover-page share count

Fielddei:EntityCommonStockSharesOutstanding

As of2026-06-30

HowThe newest cover-page count as filed, whatever its age. The float checker applies a 200-day freshness rule and sets this beside the balance-sheet count.

Open the source document →

Cash runway

Self-funding

generates cash

Full breakdown: cash runway tool

Warrants

Warrants outstanding: 308,750 underlying shares, as reported Aug 19, 2021 (20-F).

Reported exercise price: $0.28 (aggregate figure as tagged; individual tranches vary).

Balance-sheet fair value of warrants: $57,500 as of Jun 30, 2021.

Rough fully diluted estimate: 496.2M = 495.9M O/S + 308,750 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

The latest 10-Q/10-K instance document could not be checked just now, so nothing is shown rather than guessed. Try again shortly.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding	495.9M	Jun 30, 2026
+ Warrants (aggregate, as tagged) (if exercised)	308,750	Aug 19, 2021
Fully diluted estimate	496.2M	+0.1% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

F-3ASRMar 30, 2026fee exhibit found but no total offering amount (fees deferred, typical for automatic shelves)filing →

Last 12 months: 2 executed · 1 registered.

EXECUTEDMay 19, 2026Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →

REGISTEREDMar 30, 2026Automatic shelf registration — effective immediately (large filers)F-3ASR →

EXECUTEDMar 30, 2026Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →

EXECUTEDJul 20, 2021Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →

EFFECTIVEJul 15, 2021SEC declared a registration effective — selling can beginEFFECT →

MARKETINGJul 8, 2021Free-writing prospectus — offering being marketedFWP →

MARKETINGJun 30, 2021Free-writing prospectus — offering being marketedFWP →

REGISTEREDJun 23, 2021F-1/A registration — capacity to sell shares, not a sale yetF-1/A →

REGISTEREDJun 11, 2021F-1/A registration — capacity to sell shares, not a sale yetF-1/A →

REGISTEREDApr 26, 2021F-1/A registration — capacity to sell shares, not a sale yetF-1/A →

REGISTEREDMar 22, 2021F-1 registration — capacity to sell shares, not a sale yetF-1 →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full RGC workspace